The Dow Jones Industrial Average surged by over 400 points on Monday, driven by positive news from several companies. Terns Pharmaceuticals shares jumped over 20% after announcing promising data from its Phase 1 trial for a new obesity treatment. Other notable gains came from Summit Therapeutics, Relay Therapeutics, ADMA Biologics, and more.
Summit Therapeutics’ ivonescimab demonstrated a significant improvement in progression-free survival compared to Keytruda in a Phase 3 trial for non-small cell lung cancer. The drug also showed positive results in a Phase 2 trial for resectable lung cancer, highlighting its potential as a promising treatment option.
Summit Therapeutics shares surged in pre-market trading after positive clinical trial results for their cancer drug. Other notable pre-market movers include Intelligent Bio Solutions, Tonix Pharmaceuticals, and Nuburu, while Wheeler Real Estate and Golden Minerals experienced significant declines.
